Physician profile
Rafid Hussein
NPI 1396763645
$7,447.16
in general payments reported to CMS, 2019-2025
37 companies · $1,352 in 2025
The $1,352 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,175 · 2020: $1,396 · 2021: $794 · 2022: $641 · 2023: $349 · 2024: $740 · 2025: $1,352.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,440.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,440.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,425.12 | 2019-2023 | Exalt Model D |
| Abbvie INC. | $707.62 | 2019-2025 | |
| Aimmune Therapeutics, INC. | $333.39 | 2024-2025 | Zenpep |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $315.59 | 2019-2024 | Xifaxan, Relistor |
| Phathom Pharmaceuticals, INC. | $307.80 | 2024-2025 | Voquezna |
| Pfizer INC. | $294.13 | 2019-2021 | |
| Evoke Pharma, INC. | $270.43 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $256.10 | 2019-2024 | Eohilia |
| Madrigal Pharmaceuticals | $251.15 | 2025 | Rezdiffra |
| Steris Corporation | $240.93 | 2022 | |
| Cook Medical LLC | $230.76 | 2022-2024 | Hemospray |
| Omega Medical Imaging, LLC | $220.40 | 2019 | |
| Covidien LP | $178.75 | 2020 | |
| Janssen Biotech, INC. | $157.56 | 2019-2025 | Tremfya, Simponi, Stelara |
| Genzyme Corporation | $153.05 | 2022 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intercept Pharmaceuticals, INC. | $115.82 | 2019-2025 | |
| Conmed Corporation | $107.56 | 2021 | |
| Endogastric Solutions, INC | $96.00 | 2019 | |
| Olympus America INC. | $93.93 | 2019 | |
| Ethicon US, LLC | $92.53 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $87.71 | 2021 | |
| Ardelyx, INC. | $81.95 | 2025 | Ibsrela |
| Micro-Tech Endoscopy USA, INC. | $60.60 | 2021 | |
| Qol Medical, LLC | $58.36 | 2019 | |
| Celltrion USA INC. | $47.11 | 2025 | Vegzelma |
| Daiichi Sankyo INC. | $39.43 | 2019-2022 | |
| Intra-Sana Laboratories | $35.94 | 2024-2025 | Reltone 200 Mg, Glycate, Reltone 400 Mg |
| Orphalan INC | $29.32 | 2025 | Cuvrior |
| Enterra Medical, INC. | $28.43 | 2023 | |
| Braintree Laboratories, INC. | $21.07 | 2021 | |
| Exact Sciences Corporation | $18.51 | 2025 | Cologuard Collection Kit |
| Nestle Healthcare Nutrition INC. | $18.16 | 2021 | |
| Currax Pharmaceuticals LLC | $15.89 | 2025 | Contrave |
| Ambu INC. | $15.00 | 2024 | |
| Capsovision, INC. | $14.79 | 2024 | Capsocam Plus |
| Redhill Biopharma INC. | $14.53 | 2022 | |
| Shire North American Group INC | $11.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rafid Hussein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.